New 2025 Hematopoietic stem cell transplantation is effective in achieving long-term survival for post-aplastic anemia myeloid neoplasms: the EBMT Severe Aplastic Anemia Report Group Severe Aplastic Anaemia Working Party (SAAWP) 1st listed author Pedro Henrique Prata Journal Haematologica.
2025 Prognostic significance of cytogenetic risk score in patients with secondary acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-matched unrelated donors: a study from the ALWP /EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Bone Marrow Transplant.
2025 Addition of mycophenolate mofetil to a calcineurin inhibitor and post-transplant cyclophosphamide results in lower incidence of extensive chronic graft-versus-host disease in HLA-matched allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in complete remission: a matched-pair analysis on behalf of the Acute Leukemia Working Party of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Giorgia Battipaglia Journal Bone Marrow Transplant.
2025 Autologous stem cell transplantation for adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. A study by the Acute Leukemia Working Party of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Ryszard Swoboda Journal BMC Cancer.
2025 Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in active disease: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Sara Tarantino Journal Bone Marrow Transplant.
2025 GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working party Group Transplant Complications Working Party (TCWP) 1st listed author Olaf Penack Journal Leukemia.
2025 Current use of donor lymphocyte infusions after allogenic stem cell transplantation in Europe: a survey on behalf of the cellular therapy and immunobiology working party of the EBMT Group Cellular Therapy & Immunobiology Working Party (CTIWP) 1st listed author Nicole Santoro Journal Bone Marrow Transplant.
2025 Cytogenetic and molecular risk-driven conditioning intensity in acute myeloid leukemia patients undergoing stem cell transplantation with post-transplant cyclophosphamide: a study from the acute leukemia working party of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Jaime Sanz Journal Bone Marrow Transplant.
2025 Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder - recommendations from ECTRIMS and the EBMT Group Autoimmune Diseases Working Party (ADWP) 1st listed author Paolo A Muraro Journal Nat Rev Neurol.
2025 Hematopoietic stem cell transplantation for multiple sclerosis: no inflammation, no response Group Autoimmune Diseases Working Party (ADWP) 1st listed author Richard K Burt Journal Eur J Neurol.
2025 Monitoring and management of CMV and EBV after autologous haematopoietic stem cell transplantation for autoimmune diseases: a survey of the EBMT Autoimmune Diseases Working party (ADWP) Group Autoimmune Diseases Working Party (ADWP) 1st listed author Tobias Alexander Journal Bone Marrow Transplant.
2024 Nutritional aspects in autoimmune diseases undergoing hematopoietic stem cell transplantation: overview and recommendations on behalf of the EBMT ADWP and Nurses Group Group Autoimmune Diseases Working Party (ADWP) Nursing Scientific Committee 1st listed author Chiara Gandossi Journal Front Nutr.